113 related articles for article (PubMed ID: 37945405)
21. Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma.
Petrozza V; Carbone A; Bellissimo T; Porta N; Palleschi G; Pastore AL; Di Carlo A; Della Rocca C; Fazi F
Int J Mol Sci; 2015 Dec; 16(12):29219-25. PubMed ID: 26670229
[TBL] [Abstract][Full Text] [Related]
22. Profiling of Serum miRNAs Constructs a Diagnostic 3-miRNA Panel for Clear-Cell Renal Cell Carcinoma.
Li X; Wen Z; Li R; Lu C; Chen W; Chen X; Huang G; Ni L; Lai Y; Tao L
Clin Genitourin Cancer; 2024 Feb; 22(1):23-32. PubMed ID: 37574436
[TBL] [Abstract][Full Text] [Related]
23. Circular RNA hsa_circ_001895 serves as a sponge of microRNA-296-5p to promote clear cell renal cell carcinoma progression by regulating SOX12.
Chen Z; Xiao K; Chen S; Huang Z; Ye Y; Chen T
Cancer Sci; 2020 Feb; 111(2):713-726. PubMed ID: 31782868
[TBL] [Abstract][Full Text] [Related]
24. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.
Wu Y; Zhang C; Peng D; He S; Huang C; Qian J; Zhu W; Feng N; Gong Y; Li X; Zhou L
Hum Cell; 2022 Mar; 35(2):542-556. PubMed ID: 35129808
[TBL] [Abstract][Full Text] [Related]
25. Blocking lncRNA MIR155HG/miR-155-5p/-3p inhibits proliferation, invasion and migration of clear cell renal cell carcinoma.
Tao M; Zhou Y; Jin Y; Pu J
Pathol Res Pract; 2020 Feb; 216(2):152803. PubMed ID: 31889587
[TBL] [Abstract][Full Text] [Related]
26. Identification of miR-20a-5p as Robust Normalizer for Urine microRNA Studies in Renal Cell Carcinoma and a Profile of Dysregulated microRNAs.
Oto J; Herranz R; Plana E; Sánchez-González JV; Pérez-Ardavín J; Hervás D; Fernández-Pardo Á; Cana F; Vera-Donoso CD; Martínez-Sarmiento M; Medina P
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360679
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.
Moynihan MJ; Sullivan TB; Burks E; Schober J; Calabrese M; Fredrick A; Kalantzakos T; Warrick J; Canes D; Raman JD; Rieger-Christ K
Urol Oncol; 2020 Oct; 38(10):799.e11-799.e22. PubMed ID: 32534961
[TBL] [Abstract][Full Text] [Related]
28. HMGA1-mediated miR-671-5p targets APC to promote metastasis of clear cell renal cell carcinoma through Wnt signaling.
Chi XG; Meng XX; Ding DL; Xuan XH; Chen YZ; Cai Q; Wang A
Neoplasma; 2020 Jan; 67(1):46-53. PubMed ID: 31686521
[TBL] [Abstract][Full Text] [Related]
29. miR-144-3p as a novel plasma diagnostic biomarker for clear cell renal cell carcinoma.
Lou N; Ruan AM; Qiu B; Bao L; Xu YC; Zhao Y; Sun RL; Zhang ST; Xu GH; Ruan HL; Yuan CF; Han WW; Shi HC; Yang HM; Zhang XP
Urol Oncol; 2017 Jan; 35(1):36.e7-36.e14. PubMed ID: 27633984
[TBL] [Abstract][Full Text] [Related]
30. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
[No Abstract] [Full Text] [Related]
31. SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis.
Kowalczyk AE; Krazinski BE; Godlewski J; Grzegrzolka J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Dziegiel P; Kmiec Z
Cancer Genomics Proteomics; 2016; 13(3):209-17. PubMed ID: 27107063
[TBL] [Abstract][Full Text] [Related]
32. miR-30b-5p up-regulation related to the dismal prognosis for patients with renal cell cancer.
Zhang C; Pan X; Peng X; Liu K; Wang J; Zhao L; Chen X; Huang G; Li H; Ye J; Lai Y
J Clin Lab Anal; 2021 Feb; 35(2):e23599. PubMed ID: 33247622
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
[TBL] [Abstract][Full Text] [Related]
34. The lncRNA SNHG5-mediated miR-205-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1.
Xiang W; Lv L; Zhou G; Wu W; Yuan J; Zhang C; Jiang G
Cancer Med; 2020 Jun; 9(12):4251-4264. PubMed ID: 32281285
[TBL] [Abstract][Full Text] [Related]
35. Tumor miR-125b predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection.
Fu Q; Liu Z; Pan D; Zhang W; Xu L; Zhu Y; Liu H; Xu J
Cancer Sci; 2014 Nov; 105(11):1427-34. PubMed ID: 25155155
[TBL] [Abstract][Full Text] [Related]
36. MiR-212-5p inhibits the malignant behavior of clear cell renal cell carcinoma cells by targeting TBX15.
Deng JH; Zheng GY; Li HZ; Ji ZG
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10699-10707. PubMed ID: 31858538
[TBL] [Abstract][Full Text] [Related]
37. circCHST15 is a novel prognostic biomarker that promotes clear cell renal cell carcinoma cell proliferation and metastasis through the miR-125a-5p/EIF4EBP1 axis.
Gui CP; Liao B; Luo CG; Chen YH; Tan L; Tang YM; Li JY; Hou Y; Song HD; Lin HS; Xu QH; Yao GS; Yao HH; Xi-Liu ; Luo JH; Cao JZ; Wei JH
Mol Cancer; 2021 Dec; 20(1):169. PubMed ID: 34922539
[TBL] [Abstract][Full Text] [Related]
38. miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.
Chen X; Ruan A; Wang X; Han W; Wang R; Lou N; Ruan H; Qiu B; Yang H; Zhang X
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1295-304. PubMed ID: 24802708
[TBL] [Abstract][Full Text] [Related]
39. miR-155-5p Promotes Cell Proliferation and Migration of Clear Cell Renal Cell Carcinoma by Targeting PEG3.
Wu H; Wu H; Sun P; Zhu D; Ma M; Fan W
Urol Int; 2021; 105(9-10):906-915. PubMed ID: 34192708
[TBL] [Abstract][Full Text] [Related]
40. MiR-30b-5p functions as a tumor suppressor in cell proliferation, metastasis and epithelial-to-mesenchymal transition by targeting G-protein subunit α-13 in renal cell carcinoma.
Liu W; Li H; Wang Y; Zhao X; Guo Y; Jin J; Chi R
Gene; 2017 Aug; 626():275-281. PubMed ID: 28536082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
